Cargando…

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

Neuroinflammation is initiated with an aberrant innate immune response in the central nervous system (CNS) and is involved in many neurological diseases. Inflammasomes are intracellular multiprotein complexes that can be used as platforms to induce the maturation and secretion of proinflammatory cyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yueran, Yu, Haiyang, Bu, Zhongqi, Wen, Lulu, Yan, Lili, Feng, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175009/ https://www.ncbi.nlm.nih.gov/pubmed/35694441 http://dx.doi.org/10.3389/fnmol.2022.894298

Ejemplares similares

Potential Roles of Exosomes in Parkinson’s Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
por: Yu, Haiyang, et al.
Publicado: (2020)

NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia–Reperfusion Injury
por: Wang, Lixia, et al.
Publicado: (2022)

Inflammasome Proteins As Biomarkers of Multiple Sclerosis
por: Keane, Robert W., et al.
Publicado: (2018)

Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease
por: Hulse, Jonathan, et al.
Publicado: (2022)

The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
por: Zhao, Ni, et al.
Publicado: (2021)

Misfolding at the synapse: A role in amyotrophic lateral sclerosis pathogenesis?
por: Lum, Jeremy S., et al.
Publicado: (2022)

Activation of the microglial P2X7R/NLRP3 inflammasome mediates central sensitization in a mouse model of medication overuse headache
por: Wang, Yanyun, et al.
Publicado: (2023)

Inflammasomes and their roles in arthritic disease pathogenesis
por: Yang, Gabsik, et al.
Publicado: (2022)

NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
por: Leibowitz, Saskia M., et al.
Publicado: (2016)

Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis
por: Geiger, Lili, et al.
Publicado: (2023)

Receptor-Interacting Protein Kinase 3 Inhibition Relieves Mechanical Allodynia and Suppresses NLRP3 Inflammasome and NF-κB in a Rat Model of Spinal Cord Injury
por: Xue, Song, et al.
Publicado: (2022)

Focus on the Role of NLRP3 Inflammasome in Diseases
por: Fusco, Roberta, et al.
Publicado: (2020)

Role of NLRP3 inflammasome in systemic sclerosis
por: Lin, Cong, et al.
Publicado: (2022)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2018)

Gender Differences of NLRP1 Inflammasome in Mouse Model of Alzheimer's Disease
por: Zhang, Jinghang, et al.
Publicado: (2020)

Reprogramming Macrophage Metabolism and its Effect on NLRP3 Inflammasome Activation in Sepsis
por: Luo, Ruiheng, et al.
Publicado: (2022)

Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
por: Nuvolone, Mario, et al.
Publicado: (2015)

The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus
por: de Castro-Jorge, Luiza A., et al.
Publicado: (2019)

Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies
por: Huang, Gengzhen, et al.
Publicado: (2022)

The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
por: Li, Jiayue, et al.
Publicado: (2023)

Utility of the visual system to monitor neurodegeneration in multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2023)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
por: Song, Limin, et al.
Publicado: (2017)

Sleep deprivation and NLRP3 inflammasome: Is there a causal relationship?
por: Amini, Mohammad, et al.
Publicado: (2022)

Editorial: Biomarkers and therapeutic targets in the pathogenesis of neurodegenerative diseases: Functions, implications, and perspectives
por: Wang, Junhui
Publicado: (2023)

RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis
por: Acosta-Galeana, Isabel, et al.
Publicado: (2023)

The Role of Non-canonical and Canonical Inflammasomes in Inflammaging
por: Cyr, Brianna, et al.
Publicado: (2022)

Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
por: Wu, Xiaoqin, et al.
Publicado: (2017)

The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
por: Irrera, Natasha, et al.
Publicado: (2020)

NLRP3 inflammasome activation contributes to the pathogenesis of cardiocytes aging
por: Liao, Li-Zhen, et al.
Publicado: (2021)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
por: Jiang, Chunteng, et al.
Publicado: (2021)

Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients
por: Zhang, Hongliang, et al.
Publicado: (2021)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

NLRP6 Inflammasome Ameliorates Brain Injury after Intracerebral Hemorrhage
por: Wang, Peng-Fei, et al.
Publicado: (2017)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
por: Guan, Yadi, et al.
Publicado: (2020)

Perturbed Glucose Metabolism: Insights into Multiple Sclerosis Pathogenesis
por: Mathur, Deepali, et al.
Publicado: (2014)

Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022)

The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
por: Wu, Gregory F.
Publicado: (2023)

Editorial: Animal models of multiple sclerosis: can they advance future therapies?
por: DeSilva, Tara Maria, et al.
Publicado: (2023)

Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
por: Packer, Davin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_26uad0g908hvjkled2939mrncv